These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12148084)

  • 1. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits.
    Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glibenclamide and glimepiride treatment on the development of myocardial infarction in rats.
    El-Reyani NE; Baczkó I; Leprán I; Papp JG
    Acta Physiol Hung; 2000; 87(2):173-84. PubMed ID: 11205966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
    Mocanu MM; Maddock HL; Baxter GF; Lawrence CL; Standen NB; Yellon DM
    Circulation; 2001 Jun; 103(25):3111-6. PubMed ID: 11425777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation sulfonylureas preserve inhibition of mitochondrial permeability transition by the mitochondrial K+(ATP) opener nicorandil in experimental myocardial infarction.
    Argaud L; Garrier O; Loufouat J; Gomez L; Couture-Lepetit E; Gateau-Roesch O; Robert D; Ovize M
    Shock; 2009 Sep; 32(3):247-52. PubMed ID: 19174741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide).
    Klamann A; Sarfert P; Launhardt V; Schulte G; Schmiegel WH; Nauck MA
    Eur Heart J; 2000 Feb; 21(3):220-9. PubMed ID: 10639304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
    Tawfik MK; Abo-Elmatty DM; Ahmed AA
    Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of conventional sulfonylureas and glimepiride.
    Geisen K; Végh A; Krause E; Papp JG
    Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart.
    Weinbrenner C; Schulze F; Sárváry L; Strasser RH
    Cardiovasc Res; 2004 Feb; 61(3):591-9. PubMed ID: 14962489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits.
    Flynn DM; Smith AH; Treadway JL; Levy CB; Soeller WC; Boettner WA; Wisniecki P; Plowchalk DR; Gernhardt SS; Tracey WR; Knight DR
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):337-46. PubMed ID: 16382296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardioprotective effects of K(ATP) channel opener nicorandil during ischemia/ reperfusion in dogs].
    Feng L; Qiu J; Ma J; Huang XB; Cha DG; Bin JP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):157-60. PubMed ID: 15760526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning decreases the reperfusion-related formation of hydroxyl radicals in a rabbit model of regional myocardial ischemia and reperfusion: the role of K(ATP) channels.
    Raphael J; Drenger B; Rivo J; Berenshtein E; Chevion M; Gozal Y
    Free Radic Res; 2005 Jul; 39(7):747-54. PubMed ID: 16036354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of myocardial protection in type 2 diabetic patients.
    Lee TM; Chou TF
    J Clin Endocrinol Metab; 2003 Feb; 88(2):531-7. PubMed ID: 12574175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
    Iliodromitis EK; Tasouli A; Andreadou I; Bofilis E; Zoga A; Cokkinos P; Kremastinos DT
    Eur J Pharmacol; 2004 Sep; 499(1-2):163-9. PubMed ID: 15363963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction.
    Lomuscio A; Vergani D; Marano L; Castagnone M; Fiorentini C
    Coron Artery Dis; 1994 Sep; 5(9):767-71. PubMed ID: 7858767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Warm-up' phenomenon in diabetic patients with stable angina treated with diet or sulfonylureas.
    Bilinska M; Potocka J; Korzeniowska-Kubacka I; Piotrowicz R
    Coron Artery Dis; 2007 Sep; 18(6):455-62. PubMed ID: 17700217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
    Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved myocardial tolerance to ischaemia in the diabetic rabbit.
    Hadour G; Ferrera R; Sebbag L; Forrat R; Delaye J; de Lorgeril M
    J Mol Cell Cardiol; 1998 Sep; 30(9):1869-75. PubMed ID: 9769241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.